Literature DB >> 25806207

The TOPICAL study should be more topical!

Fred R Hirsch1.   

Abstract

Year:  2013        PMID： 25806207      PMCID： PMC4367651          DOI： 10.3978/j.issn.2218-6751.2012.12.01

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  2 in total

1.  High EGFR gene copy number and skin rash as predictive markers for EGFR tyrosine kinase inhibitors in patients with advanced squamous cell lung carcinoma.

Authors:  Youngjoo Lee; Hyo Sup Shim; Moo Suk Park; Joo-Hang Kim; Sang-Jun Ha; Se Hoon Kim; Byoung Chul Cho
Journal:  Clin Cancer Res       Date:  2012-01-23       Impact factor: 12.531

2.  First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.

Authors:  Siow Ming Lee; Iftekhar Khan; Sunil Upadhyay; Conrad Lewanski; Stephen Falk; Geraldine Skailes; Ernie Marshall; Penella J Woll; Matthew Hatton; Rohit Lal; Richard Jones; Elizabeth Toy; David Chao; Gary Middleton; Sue Bulley; Yenting Ngai; Robin Rudd; Allan Hackshaw; Chris Boshoff
Journal:  Lancet Oncol       Date:  2012-10-16       Impact factor: 41.316
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.